Cargando…
Mechanistic Insights into β-Lactamase-Catalysed Carbapenem Degradation Through Product Characterisation
β-Lactamases are a major threat to the clinical use of carbapenems, which are often antibiotics of last resort. Despite this, the reaction outcomes and mechanisms by which β-lactamases degrade carbapenems are still not fully understood. The carbapenem bicyclic core consists of a β-lactam ring fused...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754457/ https://www.ncbi.nlm.nih.gov/pubmed/31541180 http://dx.doi.org/10.1038/s41598-019-49264-0 |
_version_ | 1783453081375080448 |
---|---|
author | Lohans, Christopher T. Freeman, Emily I. Groesen, Emma van Tooke, Catherine L. Hinchliffe, Philip Spencer, James Brem, Jürgen Schofield, Christopher J. |
author_facet | Lohans, Christopher T. Freeman, Emily I. Groesen, Emma van Tooke, Catherine L. Hinchliffe, Philip Spencer, James Brem, Jürgen Schofield, Christopher J. |
author_sort | Lohans, Christopher T. |
collection | PubMed |
description | β-Lactamases are a major threat to the clinical use of carbapenems, which are often antibiotics of last resort. Despite this, the reaction outcomes and mechanisms by which β-lactamases degrade carbapenems are still not fully understood. The carbapenem bicyclic core consists of a β-lactam ring fused to a pyrroline ring. Following β-lactamase-mediated opening of the β-lactam, the pyrroline may interconvert between an enamine (2-pyrroline) form and two epimeric imine (1-pyrroline) forms; previous crystallographic and spectroscopic studies have reported all three of these forms in the contexts of hydrolysis by different β-lactamases. As we show by NMR spectroscopy, the serine β-lactamases (KPC-2, SFC-1, CMY-10, OXA-23, and OXA-48) and metallo-β-lactamases (NDM-1, VIM-1, BcII, CphA, and L1) tested all degrade carbapenems to preferentially give the Δ(2) (enamine) and/or (R)-Δ(1) (imine) products. Rapid non-enzymatic tautomerisation of the Δ(2) product to the (R)-Δ(1) product prevents assignment of the nascent enzymatic product by NMR. The observed stereoselectivity implies that carbapenemases control the form of their pyrroline ring intermediate(s)/product(s), thereby preventing pyrroline tautomerisation from inhibiting catalysis. |
format | Online Article Text |
id | pubmed-6754457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-67544572019-10-02 Mechanistic Insights into β-Lactamase-Catalysed Carbapenem Degradation Through Product Characterisation Lohans, Christopher T. Freeman, Emily I. Groesen, Emma van Tooke, Catherine L. Hinchliffe, Philip Spencer, James Brem, Jürgen Schofield, Christopher J. Sci Rep Article β-Lactamases are a major threat to the clinical use of carbapenems, which are often antibiotics of last resort. Despite this, the reaction outcomes and mechanisms by which β-lactamases degrade carbapenems are still not fully understood. The carbapenem bicyclic core consists of a β-lactam ring fused to a pyrroline ring. Following β-lactamase-mediated opening of the β-lactam, the pyrroline may interconvert between an enamine (2-pyrroline) form and two epimeric imine (1-pyrroline) forms; previous crystallographic and spectroscopic studies have reported all three of these forms in the contexts of hydrolysis by different β-lactamases. As we show by NMR spectroscopy, the serine β-lactamases (KPC-2, SFC-1, CMY-10, OXA-23, and OXA-48) and metallo-β-lactamases (NDM-1, VIM-1, BcII, CphA, and L1) tested all degrade carbapenems to preferentially give the Δ(2) (enamine) and/or (R)-Δ(1) (imine) products. Rapid non-enzymatic tautomerisation of the Δ(2) product to the (R)-Δ(1) product prevents assignment of the nascent enzymatic product by NMR. The observed stereoselectivity implies that carbapenemases control the form of their pyrroline ring intermediate(s)/product(s), thereby preventing pyrroline tautomerisation from inhibiting catalysis. Nature Publishing Group UK 2019-09-20 /pmc/articles/PMC6754457/ /pubmed/31541180 http://dx.doi.org/10.1038/s41598-019-49264-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Lohans, Christopher T. Freeman, Emily I. Groesen, Emma van Tooke, Catherine L. Hinchliffe, Philip Spencer, James Brem, Jürgen Schofield, Christopher J. Mechanistic Insights into β-Lactamase-Catalysed Carbapenem Degradation Through Product Characterisation |
title | Mechanistic Insights into β-Lactamase-Catalysed Carbapenem Degradation Through Product Characterisation |
title_full | Mechanistic Insights into β-Lactamase-Catalysed Carbapenem Degradation Through Product Characterisation |
title_fullStr | Mechanistic Insights into β-Lactamase-Catalysed Carbapenem Degradation Through Product Characterisation |
title_full_unstemmed | Mechanistic Insights into β-Lactamase-Catalysed Carbapenem Degradation Through Product Characterisation |
title_short | Mechanistic Insights into β-Lactamase-Catalysed Carbapenem Degradation Through Product Characterisation |
title_sort | mechanistic insights into β-lactamase-catalysed carbapenem degradation through product characterisation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754457/ https://www.ncbi.nlm.nih.gov/pubmed/31541180 http://dx.doi.org/10.1038/s41598-019-49264-0 |
work_keys_str_mv | AT lohanschristophert mechanisticinsightsintoblactamasecatalysedcarbapenemdegradationthroughproductcharacterisation AT freemanemilyi mechanisticinsightsintoblactamasecatalysedcarbapenemdegradationthroughproductcharacterisation AT groesenemmavan mechanisticinsightsintoblactamasecatalysedcarbapenemdegradationthroughproductcharacterisation AT tookecatherinel mechanisticinsightsintoblactamasecatalysedcarbapenemdegradationthroughproductcharacterisation AT hinchliffephilip mechanisticinsightsintoblactamasecatalysedcarbapenemdegradationthroughproductcharacterisation AT spencerjames mechanisticinsightsintoblactamasecatalysedcarbapenemdegradationthroughproductcharacterisation AT bremjurgen mechanisticinsightsintoblactamasecatalysedcarbapenemdegradationthroughproductcharacterisation AT schofieldchristopherj mechanisticinsightsintoblactamasecatalysedcarbapenemdegradationthroughproductcharacterisation |